Buprenorphine Pharmacology Related to Addiction Treatment - 18

Completed · Phase 2

Conditions studied: Opioid-Related Disorders

In brief

The purpose of this study is to examine the interactions between buprenorphine and naltrexone, and to assess how they may directly impact the clinical issues involving: transferring patients from buprenorphine to naltrexone, developing a non-abusable form of buprenorphine, and enhancing patient acceptability of naltrexone.

Key facts

Study ID

NCT00000236

Run by

National Institute on Drug Abuse (NIDA)

People needed

0

Last updated by the study team

2005-08-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Treatment Research Center — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.